Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post‐transplant cytoxan for sickle cell disease.

MLA

Patel, Dilan A., et al. “Early Viral Reactivation despite Excellent Immune Reconstitution Following Haploidentical Bone Marrow Transplant with Post‐transplant Cytoxan for Sickle Cell Disease.” Transplant Infectious Disease, vol. 22, no. 1, Feb. 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1111/tid.13222.

APA

Patel, D. A., Dhedin, N., Chen, H., Karnik, L., Gatwood, K., Culos, K., Mohan, S., Engelhardt, B. G., Kitko, C., Connelly, J., Satyanarayana, G., Jagasia, M., De La Fuente, J., & Kassim, A. (2020). Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post‐transplant cytoxan for sickle cell disease. Transplant Infectious Disease, 22(1), 1–10. https://doi.org/10.1111/tid.13222

Chicago

Patel, Dilan A., Nathalie Dhedin, Heidi Chen, Leena Karnik, Katie Gatwood, Katie Culos, Sanjay Mohan, et al. 2020. “Early Viral Reactivation despite Excellent Immune Reconstitution Following Haploidentical Bone Marrow Transplant with Post‐transplant Cytoxan for Sickle Cell Disease.” Transplant Infectious Disease 22 (1): 1–10. doi:10.1111/tid.13222.